clofibric acid has been researched along with Thromboembolism in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Thromboembolism: Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yildiz, A | 1 |
| Gucuk, E | 1 |
| Cay, S | 1 |
1 other study available for clofibric acid and Thromboembolism
| Article | Year |
|---|---|
A case of rhabdomyolysis and thromboembolic event secondary to fibrate monotherapy.
Topics: Acute Kidney Injury; Aged; Clofibric Acid; Humans; Hypolipidemic Agents; Male; Rhabdomyolysis; Risk | 2008 |